Insights

Compulsory licensing in Germany – the coronavirus crisis and beyond

by Dr. Anja Lunze, LL.M.

Does not patenting COVID-19 vaccines help third world countries?

Available in Hungarian

by Zoltán Novák, Ph.D.

Russian coronavirus vaccine – approval process in Hungary and the EU

Available in Hungarian

by Zoltán Novák, Ph.D.

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

by multiple authors

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

by multiple authors

Patent law in emergency situations

by David Mulder

UK brand owners prejudiced at EUIPO by combination of COVID-19 and Brexit

by Roland Mallinson

COVID-19 and Patent Law

Q&A regarding compulsory licenses and governmental use

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

End to automatic extension of UKIPO deadlines

by Louise Popple

Worldwide IPO responses to COVID-19

by Louise Popple

The EU moves towards a data-agile economy

by Mark Owen and Maria Luchian

COVID-19 postponement of MDR implementation date – how does this fit with Brexit?

by Adrian Toutoungi